Amanote Research
Register
Sign In
From Biomarker Discovery to Proteomic Validation Using Mass Spectrometry
Acta Ophthalmologica
- United States
doi 10.1111/aos.13972_210
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Ophthalmology
Date
December 1, 2018
Authors
Unknown
Publisher
Wiley
Related search
Mass Spectrometry-Based N-Glycoproteomics for Cancer Biomarker Discovery
Clinical Proteomics
Biomarker Discovery From Pancreatic Cancer Secretome Using a Differential Proteomic Approach
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
Liquid Chromatography/Mass Spectrometry (LC/MS)-Based Glycoproteomics Technologies for Cancer Biomarker Discovery
Clinical Proteomics
Molecular Medicine
Clinical Biochemistry
Molecular Biology
Straightforward and Highly Efficient Strategy for Hepatocellular Carcinoma Glycoprotein Biomarker Discovery Using a Nonglycopeptide-Based Mass Spectrometry Pipeline
Profiling the Proteomic Inflammatory State of Human Astrocytes Using DIA Mass Spectrometry
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
Future of Liquid Chromatography–mass Spectrometry in Metabolic Profiling and Metabolomic Studies for Biomarker Discovery
Biomarkers in Medicine
Biochemistry
Drug Discovery
Clinical Biochemistry
Bayesian Analysis of Mass Spectrometry Proteomic Data Using Wavelet-Based Functional Mixed Models
Biometrics
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Immunology
Biological Sciences
Medicine
Agricultural
Functional Metabolomics: From Biomarker Discovery to Metabolome Reprogramming
Protein & Cell
Biochemistry
Biotechnology
Drug Discovery
Cell Biology
Medicine
P1.04-12 Mass Spectrometry-Based Serum Proteomic Signature as a Potential Biomarker for Survival in NSCLC Patients With Immunotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
